Navigation Links
Johnson & Johnson to Participate in the 28th Annual Cowen & Company Health Care Conference
Date:3/13/2008

NEW BRUNSWICK, N.J., March 13 /PRNewswire-FirstCall/ -- Johnson & Johnson will participate in the 28th Annual Cowen & Company Health Care Conference on Thursday, March 20th at the Boston Marriott Copley Place Hotel in Boston, Massachusetts. Colleen Goggins, Worldwide Chairman, Consumer Group will represent the Company in a session scheduled at 11:00 a.m. (Eastern Time).

The webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at http://www.investor.jnj.com.

A webcast and podcast replay will be available approximately two hours after the live webcast.


'/>"/>
SOURCE Johnson & Johnson
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Johnson & Johnson to Participate in Lehman Brothers Eleventh Annual Global Healthcare Conference
2. Home Oxygen Community Applauds Senator Tim Johnson for Joining Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit
3. AHCA, Alliance Praise Bipartisan Johnson, Collins Letter Urging Rejection of Bush Medicare Cuts
4. Johnson & Johnson and NBC Olympics Partner to Share the Stories of U.S. Olympic Hopefuls and Their Journeys to Beijing With The Family Room
5. Johnson & Johnson Diabetes Institute, LLC Launches New Center to Provide State-of-the-Art Education, Training to Health Professionals
6. Eyes on Puerto Rico: Johnson & Johnson Markets New Contact Lenses Directly to Consumers
7. First Group of Minority Nurse Faculty Scholars Selected by the Johnson & Johnson Campaign for Nursings Future and AACN
8. MUSCs Hollings Cancer Center, Ralph H. Johnson VA Medical Center Partner on New TomoTherapy Treatment for Cancer Patients
9. Ravenell named recipient of grant from Robert Wood Johnson Foundation
10. Johnson City Medical Center Begins Offering Einstein Bros. Menu Items at Second On Campus Location
11. Federal Judge Says Sugar Association Suit Accusing Johnson & Johnson of False Advertising to Go Forward
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... Boca Raton, Florida (PRWEB) , ... April 24, 2017 , ... ... natural chai teas, announced its products are now available for purchase on RevNutrition.com, a ... ancient form of tea first produced and popularized in ancient India and Siam. It ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... healthcare compliance and credentialing solutions, today announced that Kyle Allain has joined the ... Cactus Provider Management sales and operations, including provider, payor and managed care solutions. ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... to be diagnosed globally; approximately 25,000 of them will be malignant.(1) As research ... of this type of healthcare model in the diagnosis and treatment of brain ...
(Date:4/24/2017)... IL (PRWEB) , ... April 24, 2017 , ... Rod ... the Senior Housing News website. , Rod has been at the forefront of Gardant ... company’s culture. As CEO, Rod has overseen the opening of more than 40 new ...
(Date:4/24/2017)... ... April 24, 2017 , ... As a former supermodel known for ... The good news for single women is that she put all the words in ... April 25th. Joan's insight, personal experiences and sparkling sense of humor have inspired her ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
Breaking Medicine Technology: